Fundraising FoxGlobal Brain — 2021 Investments
5 investments dated 2021 · listed companies and verified rows first · show all
Autify builds no-code, AI-based test automation technology for software development teams.
AI & Machine LearningDeveloper ToolsSaaSChuo-Ku, Tokyo, US
Ryo Chikazawa(Founder)inSam Yamashita(Founder)Sam Y.(Founder)inTakayuki(COO)Thomas(VP of Engineering)Chiharu(VP of Finance)
Co-investorsANOBAKAGenesia VenturesGlobis Capital PartnersLG Technology VenturesUncorrelated VenturesArchetype Ventures+5 more
Balance Re provides real-time analytics and quantitative asset-liability management (ALM) technology to help life insurers and pension funds manage capital, liquidity, and insurance and financial risks.
FintechInsurTechSaaSKöln, DE
Lucian Rautu(Co-CEO / Geschäftsführer)Michel Gauer(Co-CEO / Geschäftsführer)in
Co-investorsAnthemis Venture
Craif develops biomarker analysis and AI-driven diagnostic solutions to enable early disease detection and personalized treatment through non-invasive testing of body fluids.
AI & Machine LearningBiotechHealthtechMedical DevicesTokyo, JP
Ryuichi Onose(Founder)inYuki Ichikawa(Director)Mika Yui(Director)Ryuichi Onose Takao Yasui(Founder)
Co-investors1955 CapitalHakuhodo DY VenturesSaisei VenturesAozora Corporate InvestmentDreamers VC
.png){kind=logo}
Whitelabel buy-now-pay-later platform for retail finance at the point of sale.
Christer Holloman(Founder)Todd Latham(CEO)Anders Hallsten(Founder)Fredrik Borgquist(Founder)
Co-investorsDawn CapitalDG Daiwa VenturesDN CapitalFINTECH CircleGreen Shores CapitalMangrove Capital Partners+8 more
Zafrens develops a unified drug discovery platform that integrates isolation, imaging, and sequencing workflows to accelerate the identification of therapeutic compounds across modalities.
AI & Machine LearningBiotechDeep TechSan Diego, US
Martin SmrcinainMaina NdunguinSwamy Vijayan(Executive Officer, Director)inYi ZhanginVikas Goelin
BoardJustin Briggsin
Co-investorsAcequia Capital (AceCap)BlueYard CapitalFoundersX VenturesHAWKTAILIaso Venturesimec.xpand+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.